Mechanistically, OTUB1 deubiquitinates and stabilizes β-catenin, leading to transcriptional upregulation of c-myc and cyclin D1 while downregulating RIPK3 and MLKL, ultimately driving tumorigenesis and cisplatin resistance in BLCA. The gene discussed is RIPK3; the disease is bladder transitional cell carcinoma.